Stories from Heidelberg, Germany

24.09.2024 – 12:25
RHEACELL GmbH und Co. KG
$RHEACELL GmbH und Co. KG: RHEACELL announces FDA approval for Phase 3 study in refractory, non-curable CVU$
RHEACELL announces FDA approval for Phase 3 study in refractory, non-curable CVU
more

1